Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis

February 21, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search